Occupational Therapists in Belleville, IL Accepting Medicare

57 Occupational Therapists found. Showing 1 - 20

Therese M Seibert, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705    Fax: 618-257-0665

Tracy Parker, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705    Fax: 618-257-0665

Susan Kay Mclaughlin, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Suite 824, Belleville, IL 62223 Phone: 618-234-9705    Fax: 618-257-0665

Heather Cowden Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 305 Country Club Acres, Belleville, IL 62223 Phone: 618-973-8137

Kathryn Stump Holt, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2411 Pathways Xing, Belleville, IL 62221 Phone: 618-355-4700

Pyrkia Health Services Pllc Occupational Therapist Medicare: Medicare Enrolled Practice Location: 101 Lake Forest Dr, Belleville, IL 62220 Phone: 618-873-3710

Kristie Lynne Porter, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 106 Lincoln Place Ct, Belleville, IL 62221 Phone: 618-236-7588

Laura Ann Holobaugh, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4700 Memorial Dr, Suite 150, Belleville, IL 62226 Phone: 618-257-5250

Chelsea Rippelmeyer, OTR/L Occupational Therapist - Neurorehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-5758

Cassandra Alma Benhoff, MOT, OT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 150 N 27th St, Rehab Dept, Belleville, IL 62226 Phone: 618-781-0947

Ms. Corin L Intrieri, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2431 Glenmount Ct, Belleville, IL 62221 Phone: 618-570-1874

Kimberly Marie Huelsmann, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-5238

Mrs. Julie Ann Reichert, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 101 S Belt W, Belleville, IL 62220 Phone: 618-277-7700

Melody Middendorf, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2411 Pathways Crossing, Belleville, IL 62221 Phone: 618-355-4700

Kathleen Hart, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2810 Frank Scott Pkwy W, Suite 824, Belleville, IL 62223 Phone: 618-234-9705    Fax: 618-234-9867

Julie Rodemich Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705    Fax: 618-257-0665

Kyra Barillier, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 106 Lincoln Place Ct, Belleville, IL 62221 Phone: 618-236-7588

Mrs. Brooke Nicole Hanvey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 23 Gerri Ann Dr, Belleville, IL 62220 Phone: 618-977-9148

Kevin Bouse, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 180 S 3rd St Bldg E, Suite 30, Belleville, IL 62220 Phone: 618-234-2120    Fax: 618-222-4661

Joyce Rosenberger, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2810 Frank Scott Pkwy W, Ste 824, Belleville, IL 62223 Phone: 618-234-9705    Fax: 618-257-0665

News Archive

CytRx's clinical trials for aldoxorubicin placed on partial clinical hold

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the Company has received written notice from the United States Food and Drug Administration that its clinical trials for aldoxorubicin have been placed on partial clinical hold.

Positive interim data from Phase I/II trial of CYT387 in myelofibrosis presented at ASH Annual Meeting

YM BioSciences Inc. today announced positive interim data from the first 60 patients enrolled in the Phase I/II trial for its JAK1/JAK2 inhibitor, CYT387, in myelofibrosis. The results were reported today in an oral presentation at the 52nd American Society of Hematology Annual Meeting being held in Orlando, Florida.

Asthma and coronavirus disease - COVID-19

On the 11th of March 2020, the World Health Organization (WHO) declared COVID-19, caused by severe acute respiratory syndrome SARS CoV-2, a pandemic.

NeoStem closes share public offering; expects $6.9 million in net proceeds

NeoStem, Inc. ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced today the closing of its previously announced 5,000,000 share public offering and the exercise of the over-allotment option in full by the underwriters for an additional 750,000 shares of the Company's common stock, bringing the total shares offered to 5,750,000.

Read more Medical News

› Verified 7 days ago

• 1(current)
• 2
• 3